"Bayer [last] week put a halt to its latest courtroom battle over allegations that its weed killing products cause cancer, settling a Missouri case after four weeks of testimony and just as the trial was coming to a close and just ahead of important US Supreme Court consideration.
The confidential settlement, recorded June 16 in Missouri state court in St. Louis, came after the judge in the case denied Bayer’s motion for a directed verdict in the company’s favor that would have headed off jury deliberations. It is among many similar cases that Bayer has settled since purchasing Roundup maker Monsanto in 2018.
During the latest trial, lawyers for 54-year-old Albert Grantges argued that he developed non-Hodgkin lymphoma (NHL) because of 20 years of heavy use of “potent” formulations of glyphosate-based herbicides such as Roundup, made with the active ingredient glyphosate. Grantges used large quantities of the company’s glyphosate-based herbicide products in his work as a landscaper as well as in personal use at his home, lawyer Tobi Millrood told the jury.
During the trial, Grantges’ lawyer presented jurors with evidence that Monsanto long had knowledge of research showing a connection between glyphosate and cancer, but worked to hide the evidence rather than warning its customers. Among the evidence presented in the case were excerpts from internal corporate files that revealed secret Monsanto tactics to downplay connections between its products and cancer, including discussions of ghostwriting scientific papers that asserted glyphosate did not cause cancer."
Carey Gillam reports for The New Lede June 20, 2025.
SEE ALSO:
"WATCH: Is Bayer Losing The Roundup Fight?" (The New Lede)
Advertisement 
